Cabazitaxel for the Treatment of mCRPC: Data From the PROSELICA and FIRSTANA Trials


Neal Shore, MD, FACS, discusses data from the PROSELICA and FIRSTANA trials investigating cabazitaxel for the treatment of mCRPC, including a look at the post-hoc analyses of PROSELICA.

Related Videos
Blur image of hospital corridor | Image Credit: © zephyr_p -
blur image background of corridor in hospital or clinic image | Image Credit @ whyframeshot -
Dr. Mehmet Asim Bilen in an interview with Urology Times
Related Content
© 2024 MJH Life Sciences

All rights reserved.